Literature DB >> 10199915

Structural analysis, expression, and chromosomal localization of the mouse ikba gene.

R A Rupec1, D Poujol, J Grosgeorge, G F Carle, A Livolsi, J F Peyron, R M Schmid, P A Baeuerle, G Messer.   

Abstract

The pleiotropic transcription factor NF-kappaB is localized in the cytoplasm bound to its inhibitory subunit IkappaB. The predominant form of NF-kappaB is a p50/p65 heterodimer which can be released from IkappaB-alpha and migrate to the nucleus. Previous studies have shown that IkappaB-alpha-/- mice die 8 to 10 days postnatally, showing runting and a severe dermatitis. However, the organ distribution of mouse IkappaB-alpha, the exon-intron structure, and the chromosomal localization of ikba have not been determined so far. A mouse Sv129 genomic DNA library was screened with a human IkappaB-alpha/MAD-3 cDNA probe. One clone (P1) was isolated, spanning the complete ikba gene and the promoter/enhancer region. We show that the exon-intron structure between mouse and pig ikba is completely conserved. In contrast to human ikba, the ankyrin repeat 5 is not interrupted by an intron. Furthermore, the mouse ikba promoter contains 6 putative NF-kappaB binding sequences, which are conserved in mouse, pig, and human, underlining the importance of NF-kappaB as a key regulator of ikba transcription. The deduced amino acid sequence shows >90% similarity between mouse, pig, and human ikba. Chromosome mapping localized the mouse ikba gene to chromosome 12. Northern blot analysis demonstrated predominant expression in lymphoid tissue (lymph node and thymus). However, IkappaB-alpha mRNA was detected as well in liver tissue, the gastrointestinal tract, and the reproductive tract. The cloning and determination of the structure are a prerequisite for the construction of vectors for conditional gene targeting experiments.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199915     DOI: 10.1007/s002510050512

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  7 in total

Review 1.  Selectivity of the NF-{kappa}B response.

Authors:  Ranjan Sen; Stephen T Smale
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-14       Impact factor: 10.005

2.  Oral administration of transforming growth factor-β1 (TGF-β1) protects the immature gut from injury via Smad protein-dependent suppression of epithelial nuclear factor κB (NF-κB) signaling and proinflammatory cytokine production.

Authors:  Sheng-Ru Shiou; Yueyue Yu; Yuee Guo; Maria Westerhoff; Lei Lu; Elaine O Petrof; Jun Sun; Erika C Claud
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

3.  Enhancement of NF-kappaB activity by resveratrol in cytokine-exposed mesangial cells.

Authors:  Y Uchida; H Yamazaki; S Watanabe; K Hayakawa; Y Meng; N Hiramatsu; A Kasai; K Yamauchi; J Yao; M Kitamura
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

4.  Immune response-related gene expression profile of a novel molluscan IκB protein member from Manila clam (Ruditapes philippinarum).

Authors:  Youngdeuk Lee; Wickramaarachchige Don Niroshana Wickamarachchi; Ilson Whang; Minyoung Oh; Navaneethaiyer Umasuthan; Mahanama De Zoysa; Chulhong Oh; Do-Hyung Kang; Jehee Lee
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

5.  Estrogen modulates NFκB signaling by enhancing IκBα levels and blocking p65 binding at the promoters of inflammatory genes via estrogen receptor-β.

Authors:  Dongqi Xing; Suzanne Oparil; Hao Yu; Kaizheng Gong; Wenguang Feng; Jonathan Black; Yiu-Fai Chen; Susan Nozell
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

6.  Regulation of IkappaBalpha expression involves both NF-kappaB and the MAP kinase signaling pathways.

Authors:  Ning Zhang; Muhammad H Ahsan; Lingyun Zhu; Lidia C Sambucetti; Anthony F Purchio; David B West
Journal:  J Inflamm (Lond)       Date:  2005-10-05       Impact factor: 4.981

7.  DNA-PK is a DNA sensor for IRF-3-dependent innate immunity.

Authors:  Brian J Ferguson; Daniel S Mansur; Nicholas E Peters; Hongwei Ren; Geoffrey L Smith
Journal:  Elife       Date:  2012-12-18       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.